Hepatocellular carcinoma (HCC) is a leading cause of malignancy after renal transplantation in Asia, where hepatitis B virus infection is endemic. Early detection and resection are the key to successful treatment because the mortality rate for HCC is high. The value of β£-fetoprotein monitoring in th
Management of hepatocellular carcinoma in renal transplant recipients
β Scribed by Kenneth S. Chok; Chi Ming Lam; Fu Keung Li; Kelvin K. Ng; Ronnie T. Poon; Chung Mau Lo; Sheung Tat Fan
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 61 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The 10βyear risk of developing a solid malignancy is 20% for kidney transplant recipients. The goal of the current study was to investigate the epidemiology and the diagnostic and prognostic parameters associated with de novo malignancies of the native kidney among transp
The association between renal transplantation and malignancy, particularly histiocytic lymphoma, is well known. Hodgkin's disease also occurs in renal transplant recipients. We report such a case and also review three other reports in the literatures. The Hodgkin's disease was insensitive to convent